Previous studies suggested that CTLA4 accelerates the progression of ccRCC and is associated with OS, progression‐free survival (PFS) and disease‐free survival (DFS) in ccRCC patients.8, 36. The gene discussed is CTLA4; the disease is nonpapillary renal cell carcinoma.